Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2374143rdf:typepubmed:Citationlld:pubmed
pubmed-article:2374143lifeskim:mentionsumls-concept:C0007600lld:lifeskim
pubmed-article:2374143lifeskim:mentionsumls-concept:C0596402lld:lifeskim
pubmed-article:2374143lifeskim:mentionsumls-concept:C0008838lld:lifeskim
pubmed-article:2374143lifeskim:mentionsumls-concept:C0032207lld:lifeskim
pubmed-article:2374143lifeskim:mentionsumls-concept:C0441655lld:lifeskim
pubmed-article:2374143lifeskim:mentionsumls-concept:C0205177lld:lifeskim
pubmed-article:2374143lifeskim:mentionsumls-concept:C0332325lld:lifeskim
pubmed-article:2374143lifeskim:mentionsumls-concept:C1704241lld:lifeskim
pubmed-article:2374143lifeskim:mentionsumls-concept:C0456387lld:lifeskim
pubmed-article:2374143lifeskim:mentionsumls-concept:C0679622lld:lifeskim
pubmed-article:2374143lifeskim:mentionsumls-concept:C0205314lld:lifeskim
pubmed-article:2374143lifeskim:mentionsumls-concept:C0043780lld:lifeskim
pubmed-article:2374143pubmed:issue8lld:pubmed
pubmed-article:2374143pubmed:dateCreated1990-8-30lld:pubmed
pubmed-article:2374143pubmed:abstractTextThe in vitro cytotoxicity and in vivo antitumor activity of bis(platinum) complexes of general formula [(PtX2-(L))2H2N(CH2)nNH2] (L = NH3, X = Cl or X2 = malonato or where L = py, X = Cl) is reported. Chloride complexes [(PtCl2(NH3]2H2N(CH2)nNH2] may exist as three possible isomers: those containing both coordination units in the cis configuration (2,2/c,c), both coordination units in the trans configuration (2,2/t,t), and the mixed cis,trans species (2,2/c,t), whose synthesis is reported here. The preparation of further complexes with sterically hindered diamine backbones, such as 2,5-dimethyl-2,5-hexanediamine, is exemplified. The biological activity of all complexes were compared. The 2,2/c,c complexes are particularly active in tissue culture in cells resistant both to cisplatin and its 1,2-diaminocyclohexane (dach) analogue. The inhibition of DNA synthesis in L1210/0 cells by the 2,2/c,c complexes is equivalent to that of cisplatin. The presence of at least one cis-[Pt(amine)2] unit appears necessary for activity in cell lines sensitive to cisplatin.lld:pubmed
pubmed-article:2374143pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2374143pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2374143pubmed:languageenglld:pubmed
pubmed-article:2374143pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2374143pubmed:citationSubsetIMlld:pubmed
pubmed-article:2374143pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2374143pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2374143pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2374143pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2374143pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2374143pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2374143pubmed:statusMEDLINElld:pubmed
pubmed-article:2374143pubmed:monthAuglld:pubmed
pubmed-article:2374143pubmed:issn0022-2623lld:pubmed
pubmed-article:2374143pubmed:authorpubmed-author:CoxD MDMlld:pubmed
pubmed-article:2374143pubmed:authorpubmed-author:HackerM PMPlld:pubmed
pubmed-article:2374143pubmed:authorpubmed-author:FarrellNNlld:pubmed
pubmed-article:2374143pubmed:issnTypePrintlld:pubmed
pubmed-article:2374143pubmed:volume33lld:pubmed
pubmed-article:2374143pubmed:ownerNLMlld:pubmed
pubmed-article:2374143pubmed:authorsCompleteYlld:pubmed
pubmed-article:2374143pubmed:pagination2179-84lld:pubmed
pubmed-article:2374143pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:2374143pubmed:meshHeadingpubmed-meshheading:2374143-...lld:pubmed
pubmed-article:2374143pubmed:meshHeadingpubmed-meshheading:2374143-...lld:pubmed
pubmed-article:2374143pubmed:meshHeadingpubmed-meshheading:2374143-...lld:pubmed
pubmed-article:2374143pubmed:meshHeadingpubmed-meshheading:2374143-...lld:pubmed
pubmed-article:2374143pubmed:meshHeadingpubmed-meshheading:2374143-...lld:pubmed
pubmed-article:2374143pubmed:meshHeadingpubmed-meshheading:2374143-...lld:pubmed
pubmed-article:2374143pubmed:meshHeadingpubmed-meshheading:2374143-...lld:pubmed
pubmed-article:2374143pubmed:meshHeadingpubmed-meshheading:2374143-...lld:pubmed
pubmed-article:2374143pubmed:meshHeadingpubmed-meshheading:2374143-...lld:pubmed
pubmed-article:2374143pubmed:meshHeadingpubmed-meshheading:2374143-...lld:pubmed
pubmed-article:2374143pubmed:meshHeadingpubmed-meshheading:2374143-...lld:pubmed
pubmed-article:2374143pubmed:meshHeadingpubmed-meshheading:2374143-...lld:pubmed
pubmed-article:2374143pubmed:meshHeadingpubmed-meshheading:2374143-...lld:pubmed
pubmed-article:2374143pubmed:meshHeadingpubmed-meshheading:2374143-...lld:pubmed
pubmed-article:2374143pubmed:meshHeadingpubmed-meshheading:2374143-...lld:pubmed
pubmed-article:2374143pubmed:year1990lld:pubmed
pubmed-article:2374143pubmed:articleTitleCytotoxicity and antitumor activity of bis(platinum) complexes. A novel class of platinum complexes active in cell lines resistant to both cisplatin and 1,2-diaminocyclohexane complexes.lld:pubmed
pubmed-article:2374143pubmed:affiliationDepartment of Chemistry, University of Vermont, Burlington 05405.lld:pubmed
pubmed-article:2374143pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2374143pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:2374143pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:2374143pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...http://linkedlifedata.com/r...pubmed-article:2374143lld:chembl
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2374143lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2374143lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2374143lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2374143lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2374143lld:pubmed